Evaluation of Bone Metabolism Biomarkers in Periodontal Diseases
Primary Purpose
Periodontal Diseases
Status
Completed
Phase
Not Applicable
Locations
Turkey
Study Type
Interventional
Intervention
ELISA
Sponsored by
About this trial
This is an interventional diagnostic trial for Periodontal Diseases focused on measuring periodontitis, saliva, sclerostin
Eligibility Criteria
Inclusion Criteria: 18-65 years old. not having any systemic disease that may affect periodontal status not smoking and alcohol use volunteer to participate in the study Exclusion Criteria: periapical pathologies; resulting from orthodontics and occlusion extreme forces, including mechanical forces; chronic high-dose steroid therapy; radiation or immunosuppressive therapy; pregnancy; breastfeeding; allergy or sensitivity to any medication. Periodontal therapy or drug therapy for at least 6 months of study participants
Sites / Locations
- Necmettin Erbakan University
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Experimental
Experimental
Arm Label
periodontitis
gingivitis
periodontal healthy
Arm Description
Outcomes
Primary Outcome Measures
Evaluation of bone metabolism biomarkers in different periodontal conditions
The levels of bone metabolism markers in the saliva of individuals with different periodontal status were compared and the relationship of these markers with periodontal status was examined.
Secondary Outcome Measures
Probing pocket depth
Probing pocket depth(PPD) was measured for determining the severity of the disease and clinical outcome. High probing depth shows more severe periodontal disease.
Gingival index
The differences in gingival index scores between periodontally healthy and periodontitis.The gingival index was recorded for determining and classifying gingival status. The gingival index (Gİ) scores each site on a 0 being normal and 3 being severe inflammation characterized by edema, redness, swelling and spontaneous bleeding.
Plaque index
The differences in plaque index scores between periodontally healthy and periodontitis. Plaque index (PI) was recorded for determining and classifying oral hygiene status. The plaque index (PI) scores each site on a with 0 being no plaque in gingival area and 3 abundance of soft matter within the gingival pocket and/or on the gingival margin and adjacent tooth surface.
Full Information
NCT ID
NCT05702892
First Posted
January 9, 2023
Last Updated
January 18, 2023
Sponsor
Necmettin Erbakan University
1. Study Identification
Unique Protocol Identification Number
NCT05702892
Brief Title
Evaluation of Bone Metabolism Biomarkers in Periodontal Diseases
Official Title
Evaluation Of Biomarkers Associated With Bone Metabolism İn Patients With Different Periodontal Status
Study Type
Interventional
2. Study Status
Record Verification Date
January 2023
Overall Recruitment Status
Completed
Study Start Date
November 5, 2020 (Actual)
Primary Completion Date
May 5, 2021 (Actual)
Study Completion Date
November 5, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Necmettin Erbakan University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
This study evaluates the levels of biomarkers associated with bone metabolism in patients with different periodontal conditions.
Detailed Description
Background: In this study, the levels of bone metabolism markers found in the saliva of individuals with different periodontal conditions were compared and the relationship of these markers with periodontal status was examined.
Method: A total of 60 individuals, 20 with periodontitis (P), 20 with gingivitis (G), and 20 with periodontal healthy (S), were included in the study. Periodontal clinical parameters (plaque index, gingival index, bleeding on probing, clinical attachment level and probing pocket depth) and saliva samples were obtained from the individuals. Bone metabolism biomarker (necrotizing factor (TNF)-α, osteoprotegerin (OPG), nuclear factor kappa-β receptor activator ligand (RANKL) and sclerostin) levels in saliva samples were evaluated by enzyme-linked immunosorbent assay (ELISA).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Periodontal Diseases
Keywords
periodontitis, saliva, sclerostin
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
60 (Actual)
8. Arms, Groups, and Interventions
Arm Title
periodontitis
Arm Type
Experimental
Arm Title
gingivitis
Arm Type
Experimental
Arm Title
periodontal healthy
Arm Type
Experimental
Intervention Type
Diagnostic Test
Intervention Name(s)
ELISA
Intervention Description
ELISA(enzyme-linked immunosorbent assay)
Primary Outcome Measure Information:
Title
Evaluation of bone metabolism biomarkers in different periodontal conditions
Description
The levels of bone metabolism markers in the saliva of individuals with different periodontal status were compared and the relationship of these markers with periodontal status was examined.
Time Frame
baseline
Secondary Outcome Measure Information:
Title
Probing pocket depth
Description
Probing pocket depth(PPD) was measured for determining the severity of the disease and clinical outcome. High probing depth shows more severe periodontal disease.
Time Frame
baseline
Title
Gingival index
Description
The differences in gingival index scores between periodontally healthy and periodontitis.The gingival index was recorded for determining and classifying gingival status. The gingival index (Gİ) scores each site on a 0 being normal and 3 being severe inflammation characterized by edema, redness, swelling and spontaneous bleeding.
Time Frame
baseline
Title
Plaque index
Description
The differences in plaque index scores between periodontally healthy and periodontitis. Plaque index (PI) was recorded for determining and classifying oral hygiene status. The plaque index (PI) scores each site on a with 0 being no plaque in gingival area and 3 abundance of soft matter within the gingival pocket and/or on the gingival margin and adjacent tooth surface.
Time Frame
baseline
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
18-65 years old.
not having any systemic disease that may affect periodontal status
not smoking and alcohol use
volunteer to participate in the study
Exclusion Criteria:
periapical pathologies;
resulting from orthodontics and occlusion extreme forces, including mechanical forces;
chronic high-dose steroid therapy;
radiation or immunosuppressive therapy;
pregnancy;
breastfeeding;
allergy or sensitivity to any medication.
Periodontal therapy or drug therapy for at least 6 months of study participants
Facility Information:
Facility Name
Necmettin Erbakan University
City
Konya
Country
Turkey
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Evaluation of Bone Metabolism Biomarkers in Periodontal Diseases
We'll reach out to this number within 24 hrs